
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (Germany), Germany, covering academic research published from 2006 to 2024. Read More.
Open Access Percentage
47%
Total
Publications
51
Total Open
Publications
24
Total
Citations
1.4K
Open Access
Percentage
47%
Total
Publications
51
Total Open
Publications
24
Total
Citations
1.4K
Breakdown
Publisher Open
14%
Both
27%
Other Platform Open
6%
Closed
53%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 24%
5
Hybrid 52%
11
No Guarantees 24%
5
Other Platform Open
Institution 47%
8
Domain 47%
8
Other Internet 18%
3
Public 6%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 8 |
DOI | Other Internet | 3 |
Royal Netherlands Academy of Arts and Sciences | Institution | 2 |
University of Bristol | Institution | 1 |
University College of Arts Crafts and Design | Institution | 1 |
Universidade Federal de São Paulo | Institution | 1 |
Servicio Gallego de Salud | Institution | 1 |
Ministerio de Educación Cultura y Deporte | Institution | 1 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 1 |
Figshare | Public | 1 |